1. Misuse of drugs: annual statement of compliance

    Annual statement of compliance with the requirements of the misuse of drugs legislation for year ending 31 December 2008.

  2. ACMD open meeting 12 June 2014: registration form

    Complete this form to attend the 'Diversion and Illicit Supply of Medicines Inquiry – Evidence Gathering' open meeting of the Advisory Council on the Misuse of Drugs.

See more services in this topic

Guidance and regulation

  1. Controlled drugs list
  2. Drug misuse and dependence: UK guidelines on clinical management
  3. Precursor chemical licensing
  4. Young people drug and alcohol treatment business definitions
  5. FRANK posters
See more guidance and regulation in this topic

News and communications

  1. Prescribing of controlled drugs by therapeutic radiographers: further advice
  2. Circular 018/2018: rescheduling of cannabis-based products for medicinal use in humans
  3. Advice on the anticonvulsant drugs Pregabalin and Gabapentin
  4. Cannabis-derived medicinal products to be made available on prescription
See more news and communications in this topic

Research and statistics

  1. Substance misuse treatment in secure settings: 2017 to 2018
  2. Public Health NI - Fact Sheet 2018
  3. Substance misuse treatment for young people: statistics 2017 to 2018
  4. Review of the Psychoactive Substances Act 2016
  5. Forensic early warning system (FEWS) annual report
See more research and statistics in this topic

Policy papers and consultations

  1. Prescribed medicines review: expert group terms of reference
  2. Cannabis-based medicines expert panel: terms of reference
  3. Drug strategy 2017
  4. Plant cannabinoids: ACMD report
  5. Diversion & illicit supply of medicines
See more policy papers and consultations in this topic

Transparency and freedom of information releases

  1. Commissioning impact on drug treatment
  2. Drug strategy 2016: development review
  3. Psychoactive Substances Bill: evaluation review
  4. Methiopropamine: a review of the evidence of use and harm
  5. Methylphenidate base and methylphenidate hydrochloride importation, 2010 to 2012
See more transparency and freedom of information releases in this topic